Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_assertion description "[The validated primary endpoint assay, a peptide-specific CD8+ IFNgamma ELISPOT, was tested in a pre-trial study and found to be suitable for the detection of low frequency naturally occurring CEA- and prostate-derived tumour-antigen-specific T cells in patients with CEA-expressing malignancies and prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_assertion evidence source_evidence_literature NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_assertion SIO_000772 19066888 NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_assertion wasDerivedFrom befree-2016 NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_assertion wasGeneratedBy ECO_0000203 NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.
- befree-2016 importedOn "2016-02-19" NP708091.RAC6EnKaFSo4oZKro_0O7d0vBFxFu4SoYLbkeLr4ZpW5A130_provenance.